Literature DB >> 2842943

The late promoter of the human papovavirus BK is contained within the early promoter enhancer region.

J A Cassill1, S Subramani.   

Abstract

We have analyzed the sequences necessary for late promoter function and mapped the late mRNA start sites of the human papovavirus BK (prototype). Our results show that, under both replicating and nonreplicating conditions, the BKV late promoter is contained within the same region defined as the enhancer for the early promoter. This region consists of three 68-bp repeats (the middle one of which has an 18-bp deletion) and a 66-bp region containing an enhancer element denoted as c, located to the late side of the 68-bp repeats. Deletions within the early enhancer domain indicate that elements of the late promoter are found throughout the entire region.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2842943     DOI: 10.1016/0042-6822(88)90159-6

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  4 in total

1.  PEA1 and PEA3 enhancer elements are primary components of the polyomavirus late transcription initiator element.

Authors:  W Yoo; M E Martin; W R Folk
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

2.  Promoter evolution in BK virus: functional elements are created at sequence junctions.

Authors:  R B Markowitz; S Tolbert; W S Dynan
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

3.  At least two types of control regions can be found among naturally occurring BK virus strains.

Authors:  A Sundsfjord; T Johansen; T Flaegstad; U Moens; P Villand; S Subramani; T Traavik
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

4.  In vivo expression of a single viral DNA-binding protein generates systemic lupus erythematosus-related autoimmunity to double-stranded DNA and histones.

Authors:  U Moens; O M Seternes; A W Hey; Y Silsand; T Traavik; B Johansen; O P Rekvig
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.